A lncRNA from the FTO Locus Acts as a Suppressor of the m⁶A Writer Complex and p53 Tumor Suppression Signaling

Researchers demonstrated that FTO-IT1 long noncoding RNA (lncRNA) was upregulated and positively correlated with poor survival of patients with wild-type p53-expressing prostate cancer.